Company
Headquarters: Buenos Aires, Argentina
Employees: 400
CEO: Juan Manuel Artola
AR$57.62 Billion
ARS as of Jan. 1, 2024
US$71.1 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antivirals for the treatment of HIV and HCV; oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, cholesterol-lowering, and anti platelet drugs; and psychiatric drugs comprising analgesic, anti psychotic, anti depressive, anti dementia, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is based in Buenos Aires, Argentina.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Laboratorios Richmond S.A.C.I.F. has the following listings and related stock indices.
Stock: BCBA: RICH wb_incandescent